Cystinuria clinical trials
The registry lists 23 studies for Cystinuria across 8 countries. 5 are recruiting or about to start. Per ClinicalTrials.gov, last updated 2026-08-07.
Status
- Completed
- 10
- Recruiting
- 5
- Status unknown
- 3
- Withdrawn
- 3
- Active, not recruiting
- 2
Phase
- Phase 2
- 9
- Phase 3
- 2
- Phase 1
- 1
- Phase 4
- 1
Where
- United States
- 16
- Iceland
- 3
- Belgium
- 3
- France
- 3
- United Kingdom
- 1
- Canada
- 1
Who runs them
NYU Langone Health (5) · Mayo Clinic (5) · Advicenne Pharma (2) · University of California, San Francisco (2) · Indiana Kidney Stone Institute (1) · Devicare S.L. (1) · Universitaire Ziekenhuizen KU Leuven (1) · European Georges Pompidou Hospital (1)
Studies
Recruiting first, then most recently updated. Showing 23 of 23 — search for more.
- Prospective Research Rare Kidney Stones (ProRKS)RecruitingNCT027802974 countries
- Rare Kidney Stone Consortium BiobankRecruitingNCT020263881 country
- Rare Kidney Stone Consortium Patient RegistryRecruitingNCT005885622 countries
- Monogenic Kidney Stone - Genetic TestingRecruitingNCT033058351 country
- National Registry of Rare Kidney DiseasesRecruitingNCT060658521 country
- Lipoic Acid Supplement for Cystine StoneCompletedNCT02910531Phase 21 country
- Study Evaluating Patients With Cystinuria and Efficacy and Safety Exploratory Study in the Youngest ChildrenWithdrawnNCT04147871Phase 2/32 countries
- The Effect of Sodium-glucose Cotransporter (SGLT) 2 Inhibitors on Cystine Stone Formation: A Preliminary StudyCompletedNCT04818034Phase 21 country
- Long Term Clinical Efficacy of Sodium-glucose Cotransporter-2 (SGLT-2) Inhibitor in CystinuricsWithdrawnNCT05058859Phase 21 country
- Randall's Plaque Study: Pathogenesis and Relationship to NephrolithiasisActive, not recruitingNCT00169806Not applicable1 country
- PREPL in Health and DiseaseActive, not recruitingNCT02263781Not applicable1 country
- Study Evaluating Patients With CystinuriaWithdrawnNCT04137978Phase 2/32 countries
- Registry of Thiola EC TherapyCompletedNCT050485631 country
- Health-related Quality of Life in Rare Kidney StoneCompletedNCT021243952 countries
- Effect of Urine Alkalinazation on Urinary Inflammatory Markers in Patients With CystinuriaCompletedNCT038361441 country
- Effect of Increasing Doses of Tiopronin on Cystine Capacity in Patients With CystinuriaCompletedNCT03663855Phase 21 country
- Effect of Increasing Doses of Cystine Binding Thiol Drugs on Cystine Capacity in Patients With CystinuriaCompletedNCT02125721Phase 41 country
- TCUPS- Tolvaptan Use in Cystinuria and Urolithiasis: A Pilot StudyCompletedNCT02538016Not applicable1 country
- Cystine Capacity Clinical Study (CysCap)CompletedNCT021201051 country
- This Study Evaluates the Superiority of Daily Self-pH Monitorization of Lit-control®pH Meter Compared to the Monitorization of Reactive Strips (Standard of Care).Status unknownNCT03539926Not applicable1 country
- Bucillamine Phase 2 Trial in Patients With CystinuriaStatus unknownNCT02942420Phase 21 country
- Use of an Herbal Preparation to Prevent and Dissolve Kidney StonesCompletedNCT00381849Phase 1/21 country
- Sulfamethoxazole for the Treatment of Primary PREPL DeficiencyStatus unknownNCT02640443Phase 2